Biotech Daily: Dr Boreham’s Crucible: Immuron
Immuron is in the throes of multiple clinical trials to prove the efficacy of Travelan against specific diarrhoea-inducing pathogens.
https://www.immuron.com.au/assets/files/IMC%20May%2010%2C%202024.pdf
Filter by Year:
- Immuron files FDA application for deadly C. diff infection fight
- Immuron marks surge in Travelan® sales on eve of entry into US via Walmart.com
- Biotech Daily: Dr Boreham’s Crucible: Immuron
- The Watchlist: Immuron's Travelan sales growth, clinical pipeline achievements and upcoming milestones!
- Guarding Gut Health on the Go: The Travelan® Advantage
This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.
